PDS Biotechnology
PDSB
PDSB
68 hedge funds and large institutions have $49.4M invested in PDS Biotechnology in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more ownership
Funds ownership: 23.92% → 24.93% (+1%)
45% less capital invested
Capital invested by funds: $89.3M → $49.4M (-$39.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
68
Holding in Top 10
–
Calls
$2.5M
Puts
$484K
Top Buyers
| 1 | +$2.14M | |
| 2 | +$1.24M | |
| 3 | +$891K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$842K |
| 5 |
Renaissance Technologies
New York
|
+$728K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$1.61M | |
| 3 | -$1.09M | |
| 4 |
Morgan Stanley
New York
|
-$737K |
| 5 |
KAM
Knightsbridge Asset Management
Newport Beach,
California
|
-$665K |